Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.

Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL.

Circulation. 2004 Jun 29;109(25 Suppl 1):IV6-19. Review. No abstract available.

2.

In vitro diagnosis of fibrinolysis: present status and desired improvements.

Kluft C.

Ann N Y Acad Sci. 1992 Dec 4;667:291-304. Review. No abstract available.

PMID:
1309050
3.

Biochemical markers surrogating on vascular effects of sex steroid hormones.

Mueck AO, Seeger H.

Gynecol Endocrinol. 2006 Mar;22(3):163-73. Review.

PMID:
16835080
4.

[Homocysteine].

Fukuzawa J, Hasebe N, Yao N, Koyama S, Kikuchi K.

Nihon Rinsho. 2006 Jul;64 Suppl 5:173-6. Review. Japanese. No abstract available.

PMID:
16897861
5.

Atherosclerotic plaque inflammation: the final frontier?

Aikawa M, Libby P.

Can J Cardiol. 2004 May 1;20(6):631-4. Review. No abstract available.

PMID:
15152295
6.

[Less common risk factors for atherogenesis--homocysteine, lipoprotein (a) and C-reactive protein].

Racek J, Racková M.

Cas Lek Cesk. 2002 Sep;141(19):605-9. Review. Czech.

PMID:
12501503
7.
8.

Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.

Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R.

Circulation. 2005 Mar 22;111(11):1448-54. Review. No abstract available.

9.

[Biomarkers in cardiology--state of the art 2007].

Mair J.

Wien Med Wochenschr. 2007 Feb;157(3-4):48-56. Review. German.

PMID:
17340059
10.

Therapy and clinical trials.

Abate N, Jialal I.

Curr Opin Lipidol. 2002 Aug;13(4):457-60. Review. No abstract available.

PMID:
12151863

Supplemental Content

Support Center